News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
603,779 Results
Type
Article (46240)
Company Profile (582)
Press Release (556957)
Multimedia
Podcasts (31)
Webinars (8)
Section
Business (163257)
Career Advice (2381)
Deals (30993)
Drug Delivery (108)
Drug Development (71572)
Employer Resources (138)
FDA (17009)
Job Trends (13488)
News (292791)
Policy (33304)
Tag
2024 BioCapital Digital (20)
2024 BioForest Digital (16)
2024 BioForest Standard (1)
2024 BioMidwest Digital (14)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (19)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (15)
2024 Biotech Beach Standard (8)
2024 Genetown Digital (10)
2024 Genetown Standard (8)
2024 Lone Star Bio Digital (17)
2024 Pharm Country Digital (13)
2024 Pharm Country Standard (3)
2025 BioForest Digital (6)
2025 Lone Star Bio Digital (8)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2647)
Academic (1)
Accelerated approval (5)
Adcomms (22)
Allergies (84)
Alliances (44873)
ALS (92)
Alzheimer's disease (1316)
Antibody-drug conjugate (ADC) (120)
Approvals (17011)
Artificial intelligence (273)
Autoimmune disease (22)
Automation (16)
Bankruptcy (305)
Best Places to Work (11201)
BIOSECURE Act (21)
Biosimilars (115)
Biotechnology (403)
Bladder cancer (75)
Brain cancer (27)
Breast cancer (268)
Cancer (2141)
Cardiovascular disease (171)
Career advice (1996)
Career pathing (28)
CAR-T (145)
Cell therapy (407)
Cervical cancer (20)
Clinical research (58368)
Collaboration (788)
Compensation (371)
Complete response letters (21)
COVID-19 (2698)
CRISPR (42)
C-suite (203)
Cystic fibrosis (92)
Data (2097)
Decentralized trials (2)
Denatured (5)
Depression (45)
Diabetes (266)
Diagnostics (6253)
Digital health (20)
Diversity (5)
Diversity, equity & inclusion (34)
Drug discovery (124)
Drug pricing (109)
Drug shortages (25)
Duchenne muscular dystrophy (91)
Earnings (64954)
Editorial (40)
Employer branding (17)
Employer resources (124)
Events (80232)
Executive appointments (614)
FDA (18294)
Featured Employer (46)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (8)
Funding (721)
Gene editing (103)
Generative AI (27)
Gene therapy (294)
GLP-1 (677)
Government (4672)
Grass and pollen (4)
Guidances (58)
Healthcare (17651)
Huntington's disease (17)
IgA nephropathy (27)
Immunology and inflammation (93)
Indications (27)
Infectious disease (2848)
Inflammatory bowel disease (135)
Inflation Reduction Act (8)
Influenza (49)
Intellectual property (101)
Interviews (445)
IPO (15106)
IRA (40)
Job creations (2796)
Job search strategy (1663)
Kidney cancer (9)
Labor market (31)
Layoffs (390)
Leadership (21)
Legal (7614)
Liver cancer (74)
Lung cancer (296)
Lymphoma (141)
Machine learning (7)
Management (47)
Manufacturing (315)
MASH (60)
Medical device (13226)
Medtech (13231)
Mergers & acquisitions (16430)
Metabolic disorders (638)
Multiple sclerosis (79)
NASH (10)
Neurodegenerative disease (87)
Neuropsychiatric disorders (21)
Neuroscience (1827)
NextGen: Class of 2025 (6401)
Non-profit (4283)
Northern California (2330)
Now hiring (11)
Obesity (326)
Opinion (220)
Ovarian cancer (71)
Pain (91)
Pancreatic cancer (78)
Parkinson's disease (138)
Partnered (19)
Patents (242)
Patient recruitment (106)
Peanut (49)
People (43896)
Pharmaceutical (117)
Pharmacy benefit managers (20)
Phase I (17521)
Phase II (25334)
Phase III (20144)
Pipeline (1138)
Policy (142)
Postmarket research (2502)
Preclinical (7231)
Press Release (70)
Prostate cancer (105)
Psychedelics (31)
Radiopharmaceuticals (239)
Rare diseases (363)
Real estate (4953)
Recruiting (57)
Regulatory (23183)
Reports (36)
Research institute (2344)
Resumes & cover letters (396)
Rett syndrome (5)
RNA editing (5)
RSV (49)
Schizophrenia (63)
Series A (122)
Series B (81)
Service/supplier (23)
Sickle cell disease (50)
Southern California (2110)
Special edition (15)
Spinal muscular atrophy (147)
Sponsored (32)
Startups (3188)
State (2)
Stomach cancer (16)
Supply chain (67)
Tariffs (42)
The Weekly (26)
United States (21251)
Vaccines (732)
Venture capitalists (29)
Weight loss (212)
Women's health (24)
Worklife (16)
Date
Today (146)
Last 7 days (775)
Last 30 days (2442)
Last 365 days (31111)
2025 (10006)
2024 (33123)
2023 (37236)
2022 (48158)
2021 (52133)
2020 (51147)
2019 (43967)
2018 (33758)
2017 (30915)
2016 (29368)
2015 (33630)
2014 (25224)
2013 (20680)
2012 (22442)
2011 (22733)
2010 (20242)
Location
Africa (798)
Alabama (47)
Alaska (7)
Arizona (157)
Arkansas (13)
Asia (37044)
Australia (6545)
California (5583)
Canada (1811)
China (480)
Colorado (252)
Connecticut (266)
Delaware (142)
Europe (83260)
Florida (859)
Georgia (206)
Hawaii (1)
Idaho (50)
Illinois (505)
India (27)
Indiana (283)
Iowa (12)
Japan (157)
Kansas (95)
Kentucky (16)
Louisiana (12)
Maine (61)
Maryland (848)
Massachusetts (4116)
Michigan (206)
Minnesota (341)
Mississippi (2)
Missouri (87)
Montana (25)
Nebraska (20)
Nevada (54)
New Hampshire (67)
New Jersey (1686)
New Mexico (28)
New York (1620)
North Carolina (942)
North Dakota (8)
Northern California (2330)
Ohio (193)
Oklahoma (10)
Oregon (37)
Pennsylvania (1175)
Puerto Rico (10)
Rhode Island (31)
South America (1068)
South Carolina (21)
South Dakota (1)
Southern California (2110)
Tennessee (93)
Texas (840)
Utah (167)
Virginia (154)
Washington D.C. (60)
Washington State (513)
West Virginia (3)
Wisconsin (61)
603,779 Results for "cibus us llc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Viscogliosi Brothers Completes Acquisition of U.S. Spine Business from Stryker, Creating VB Spine, LLC
April 2, 2025
·
6 min read
Press Releases
ITF Therapeutics LLC Announces Opening of New U.S. Headquarters in Concord, Massachusetts
March 5, 2025
·
6 min read
Press Releases
Therma Bright Secures an Initial Limited Exclusive U.S. Marketing and Distribution Contract for Its Consumer Products with Global Wellness Products LLC
National Distributor to Sell Cold Sore Prevention Device Through National Ecommerce Sales Through Direct to Consumer Marketing Efforts
March 13, 2025
·
4 min read
Press Releases
Marius Pharmaceuticals Partners with US Specialists Management, LLC (“USSM”) Through Affiliated Urologic In-office Dispensaries
January 14, 2025
·
7 min read
Press Releases
Innovative Lab Services LLC Acquires Compco Analytical, Inc.
May 1, 2025
·
1 min read
Manufacturing
With Pharma Throwing Billions At US Manufacturing, Where Is The Cash Going?
Major pharmaceutical companies are committing billions to US manufacturing in an effort to avoid steep tariffs threatened by President Donald Trump.
April 29, 2025
·
2 min read
·
Annalee Armstrong
Press Releases
Maxwell Biosciences Secures Anti-Diarrheal US Military Agreement
Maxwell’s 7th signed US military agreement is for in vitro testing of Maxwell’s Claromers for the treatment of diarrheal pathogens
April 23, 2025
·
3 min read
Press Releases
AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711
April 22, 2025
·
2 min read
Deals
Calyxt, Inc. Announces Effectiveness of Registration Statement on Form S-4 in Connection with Merger with Cibus Global LLC
Calyxt, Inc., a plant-based synthetic biology company, and Cibus, a leader in precision gene editing in agriculture, announced that the registration statement on Form S-4, initially filed with the U.S. Securities and Exchange Commission by Calyxt on February 14, 2023, and amended on April 14, 2023, has been declared effective by the SEC.
April 18, 2023
·
10 min read
Job Trends
Massive Investment in US Manufacturing Triggers Wave of Career Opportunities
Companies are announcing significant investments in U.S. manufacturing in response to looming tariffs. An AstraZeneca executive and Eli Lilly and Novo Nordisk spokespeople discuss potential job and skill-building opportunities and where manufacturing might head in the future.
April 24, 2025
·
6 min read
·
Angela Gabriel
1 of 60,378
Next
